Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast for cardiomyopathy in muscular dystrophy (Tranilast-MD)
jRCTs031180038Completed
- Sponsor
- National Hospital Organization
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tranilast in Cardiomyopathies and muscular dystrophy (MD), sponsored by National Hospital Organization. Primary endpoint: Change in BNP at 24 weeks. Started Dec 2018; status: completed.
02
Drugs
tranilast
03
Conditions
Cardiomyopathiesmuscular dystrophy (MD)
Beyond the preview
Go deeper on jRCTs031180038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180038.